Showing results (761-770 of 1,524) with videos related to
Sort By:
Pageof 153
CPT: Pharmacometrics & Systems Pharmacology|October 14, 2021
Exposure-response analysis of adverse events associated with molibresib and its active metabolites in patients with solid tumorsAnu Shilpa Krishnatry, Eva Hanze, Tim Bergsma, et al.CPT: Pharmacometrics & Systems Pharmacology|February 25, 2022
A novel cardiovascular systems model to quantify drugs effects on the inter-relationship between contractility and other hemodynamic variablesYu Fu, Hadi Taghvafard, Medhat M Said, et al.CPT: Pharmacometrics & Systems Pharmacology|December 19, 2022
Regulatory utility of physiologically-based pharmacokinetic modeling to support alternative bioequivalence approaches and risk assessment: A workshop summary reportFang Wu, Youssef Mousa, Kimberly Raines, et al.CPT: Pharmacometrics & Systems Pharmacology|January 4, 2023
Regulatory utility of physiologically based pharmacokinetic modeling for assessing food impact in bioequivalence studies: A workshop summary reportAbdullah Al Shoyaib, Arian Emami Riedmaier, Anita Kumar, et al.CPT: Pharmacometrics & Systems Pharmacology|May 19, 2020
Leveraging Quantitative Systems Pharmacology Approach into Development of Human Recombinant Follistatin Fusion Protein for Duchenne Muscular DystrophyHoa Q Nguyen, Andrea Iskenderian, David Ehmann, et al.CPT: Pharmacometrics & Systems Pharmacology|May 9, 2020
Physiologically-Based Pharmacokinetic Model-Informed Drug Development for Fenebrutinib: Understanding Complex Drug-Drug InteractionsYuan Chen, Fang Ma, Nicholas S Jones, et al.CPT: Pharmacometrics & Systems Pharmacology|May 1, 2021
End-to-end application of model-informed drug development for ertugliflozin, a novel sodium-glucose cotransporter 2 inhibitorDaryl J Fediuk, Gianluca Nucci, Vikas K Dawra, et al.CPT: Pharmacometrics & Systems Pharmacology|May 3, 2021
Beyond the single average tumor: Understanding IO combinations using a clinical QSP model that incorporates heterogeneity in patient responseRukmini Kumar, Kannan Thiagarajan, Lakshmanan Jagannathan, et al.CPT: Pharmacometrics & Systems Pharmacology|June 21, 2020
Mini-Review: Comprehensive Drug Disposition Knowledge Generated in the Modern Human Radiolabeled ADME StudyDouglas K Spracklin, Danny Chen, Arthur J Bergman, et al.CPT: Pharmacometrics & Systems Pharmacology|October 25, 2019
Population Pharmacokinetic/Pharmacodynamic Modeling of Methylprednisolone in Neonates Undergoing Cardiopulmonary BypassChristoph P Hornik, Daniel Gonzalez, Julie Dumond, et al.Pageof 153